FBIS3-27839 "dreas021_a_94010" FBIS-EAS-94-021 Document Type:Daily Report 1 February 1994 NORTHEAST ASIA Japan Joint Pharmaceutical Company Planned in PRC OW0102122194 Tokyo KYODO in English 1000 GMT 1 Feb 94 OW0102122194 Tokyo KYODO Language: English Article Type:BFN [Text] Osaka, Feb. 1 KYODO -- Takeda Chemical Industries Ltd. said Tuesday [1 February] it will establish a pharmaceutical production company in Tianjin, China, in March with a local pharmaceutical firm. It will be Takeda's first joint venture in China, company officials said. They said the venture, Tianjin Takeda Pharmaceuticals Co., will be capitalized at 19.2 million dollars (2 billion yen). Takeda, Japan's top pharmaceutical maker, will provide 75 percent of the capital, while the local partner Lisheng Pharmaceutical Factory Tianjin will put up 25 percent. The new factory, expected to start operation after two and a half years, will produce six drugs, including an anti-prostate cancer agent and a cerebral vasodilator. It will market the products in China where the need for health care is growing, the officials said. The new venture is expected to post about 2 billion yen in sales in 1997, they added.
